BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12933795)

  • 1. Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection.
    Stewart RS; Harris DA
    J Biol Chem; 2003 Nov; 278(46):45960-8. PubMed ID: 12933795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C-terminal globular domain of the prion protein is necessary and sufficient for import into the endoplasmic reticulum.
    Heske J; Heller U; Winklhofer KF; Tatzelt J
    J Biol Chem; 2004 Feb; 279(7):5435-43. PubMed ID: 14645231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Most pathogenic mutations do not alter the membrane topology of the prion protein.
    Stewart RS; Harris DA
    J Biol Chem; 2001 Jan; 276(3):2212-20. PubMed ID: 11053411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attempts to convert the cellular prion protein into the scrapie isoform in cell-free systems.
    Raeber AJ; Borchelt DR; Scott M; Prusiner SB
    J Virol; 1992 Oct; 66(10):6155-63. PubMed ID: 1356161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A transmembrane form of the prion protein contains an uncleaved signal peptide and is retained in the endoplasmic Reticulum.
    Stewart RS; Drisaldi B; Harris DA
    Mol Biol Cell; 2001 Apr; 12(4):881-9. PubMed ID: 11294893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of carboxyl-terminal domain translocation during prion protein biogenesis.
    De Fea KA; Nakahara DH; Calayag MC; Yost CS; Mirels LF; Prusiner SB; Lingappa VR
    J Biol Chem; 1994 Jun; 269(24):16810-20. PubMed ID: 7911469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transmembrane form of the prion protein in neurodegenerative disease.
    Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
    Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell membrane translocation of the N-terminal (1-28) part of the prion protein.
    Lundberg P; Magzoub M; Lindberg M; Hällbrink M; Jarvet J; Eriksson LE; Langel U; Gräslund A
    Biochem Biophys Res Commun; 2002 Nov; 299(1):85-90. PubMed ID: 12435392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmissible and genetic prion diseases share a common pathway of neurodegeneration.
    Hegde RS; Tremblay P; Groth D; DeArmond SJ; Prusiner SB; Lingappa VR
    Nature; 1999 Dec; 402(6763):822-6. PubMed ID: 10617204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-translational import of the prion protein into the endoplasmic reticulum interferes with cell viability: a critical role for the putative transmembrane domain.
    Heller U; Winklhofer KF; Heske J; Reintjes A; Tatzelt J
    J Biol Chem; 2003 Sep; 278(38):36139-47. PubMed ID: 12853456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion protein contains a second endoplasmic reticulum targeting signal sequence located at its C terminus.
    Hölscher C; Bach UC; Dobberstein B
    J Biol Chem; 2001 Apr; 276(16):13388-94. PubMed ID: 11278343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the properties and trafficking of an anchorless form of the prion protein.
    Campana V; Caputo A; Sarnataro D; Paladino S; Tivodar S; Zurzolo C
    J Biol Chem; 2007 Aug; 282(31):22747-56. PubMed ID: 17556367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylation deficiency at either one of the two glycan attachment sites of cellular prion protein preserves susceptibility to bovine spongiform encephalopathy and scrapie infections.
    Neuendorf E; Weber A; Saalmueller A; Schatzl H; Reifenberg K; Pfaff E; Groschup MH
    J Biol Chem; 2004 Dec; 279(51):53306-16. PubMed ID: 15448157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cryptic nuclear localization signals in the prion protein.
    Gu Y; Hinnerwisch J; Fredricks R; Kalepu S; Mishra RS; Singh N
    Neurobiol Dis; 2003 Mar; 12(2):133-49. PubMed ID: 12667468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid conditions near the GPI anchor attachment site of prion protein for the conversion and the GPI anchoring.
    Hizume M; Kobayashi A; Mizusawa H; Kitamoto T
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1681-6. PubMed ID: 20040362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutant prion protein displays an aberrant membrane association when expressed in cultured cells.
    Lehmann S; Harris DA
    J Biol Chem; 1995 Oct; 270(41):24589-97. PubMed ID: 7592679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic mutations in the glycosylphosphatidylinositol signal peptide of PrP modulate its topology in neuroblastoma cells.
    Gu Y; Singh A; Bose S; Singh N
    Mol Cell Neurosci; 2008 Apr; 37(4):647-56. PubMed ID: 18325785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polar substitutions in helix 3 of the prion protein produce transmembrane isoforms that disturb vesicle trafficking.
    Sanchez-Garcia J; Arbelaez D; Jensen K; Rincon-Limas DE; Fernandez-Funez P
    Hum Mol Genet; 2013 Nov; 22(21):4253-66. PubMed ID: 23771030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotranslational partitioning of nascent prion protein into multiple populations at the translocation channel.
    Kim SJ; Hegde RS
    Mol Biol Cell; 2002 Nov; 13(11):3775-86. PubMed ID: 12429823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.